Introduction
Neisseria meningitidis is a member of the gram-negative cocci and mostly its serogroups A, B, C, W135, and Y contribute to human diseases (1) . Up to 10% of the world's population may be asymptomatic carriers with nasopharyngeal colonization, but higher rates can be seen in crowded settings such as prisons, universities, schools, immigrant camps, and military institutions (1, 2) . N. meningitidis is responsible for meningitis and sepsis, and delayed or undertreated cases are associated with mortality rates above 50%. Moreover, even with prompt treatment, meningococcal meningitis leads to death in 5% to 10% of cases (2) . Transmission occurs through breathing aerosols by people who have had close or extended contact with an infected patient, such as those in the same household and shelters, roommates, and pilgrims. The development of invasive MCD is dependent upon a wide variety of bacterial, host, and environmental factors. Risk is highest among travelers who have prolonged contact with local populations in the meningitis belt during an epidemic (3). The Hajj pilgrimage to Saudi Arabia has been associated with outbreaks of meningococcal disease in returning pilgrims and those in contact with them (4). Every year, about 3 million people from over 140 countries meet in Medina and Mecca for nearly 30 days (5, 6) . The incidence of meningococcal disease is several times higher in the meningitis belt and Saudi Arabia than in Iran and other countries, with periodic epidemics during the dry season (December-June) (3) (4) (5) (6) (7) .
In 1987, a N. meningitidis serogroup previously isolated in East Asia and Europe occurred among the pilgrims, and spread globally when the pilgrims returned to their home countries (7) (8) (9) . Then an outbreak of serogroup W-135 MCD occurred in mid-March 2000 among Muslim pilgrims returning from the pilgrimage to Mecca and those in contact with them, with more than 340 cases being reported from around the world (4, 10) . Recent studies showed that W-135 and B were the commonest serogroups causing meningococcal meningitis (11, 12) . The risk of transmission increases owing to the fact that carriage may last between 5 and 15 weeks (13) (14) (15) . In the study by Wilder-Smith et al., 15% of pilgrims were carriers of N. meningitidis following their return from pilgrimage, and interestingly 55% of these carriers tested positive during the next 6 months (16). Another study, by Ceyhan et al. in 2010 in Turkey, showed serogroup W135 to be responsible for most carriage cases among pilgrims, despite their being vaccinated with the quadrivalent vaccine. Moreover, the carriers transmitted the pathogen to their family members, and account for the main source of W135 in Turkey (17) .
As there are few studies on pharyngeal carriage among pilgrims in Iran, especially in this region (5), we decided to study and to compare the carrier status of N. meningitidis among pilgrims going to and pilgrims returning from the Hajj.
Materials and methods
This cross-sectional and prospective study included Hajj pilgrims from Zahedan in Iran in 2012. All pilgrims who agreed to participate and who had not taken antibiotics in the previous 7 days were enrolled in the study. The pilgrims were tested twice: before departure from their home country and after returning from the pilgrimage. Pharyngeal swab sampling was performed in each pilgrim at the waiting hall of the airport, and the swab was maintained in Stuart Transport Medium until transmission to the laboratory. The specimen was cultured on modified Thayer-Martin and blood agar medium for 24 h. Following Gram staining of the obtained colonies, gram-negative diplococci were identified by oxidase and carbohydrate consumption tests. The carrier status for N. meningitidis was defined as a positive culture of the pharyngeal swab sample for the organism. Then carrier rate was compared in Hajj pilgrims before departure and after returning to Zahedan, Iran.
Statistical analysis
The results were analyzed using SPSS 22.0 for Windows to calculate significant differences and P ≤ 0.05 was considered statistically significant.
Results
A total of 422 individuals were included in this study (42.2% male, 57.8% female). The mean ± SD age of subjects was 50.18 ± 11.09 years. Of these, 268 (63.5%) mentioned a previous pilgrimage and 247 (58.5%) reported a history of antibiotic use during the Hajj pilgrimage. Before-trip sampling revealed 2 cases of Neisseria sicca (0.5%) and 11 cases of Moraxella catarrhalis (2.6%). However, no N. meningitidis colony was grown on the culture. Post-trip sampling showed 49 cases of N. sicca (11.6%), 15 cases of M. catarrhalis (3.6%), and 6 cases of N. meningitidis (1.4%) (Table) . Among the patients with positive culture of N. meningitides, 2 (33.3%) were aged < 40 years, 3 were (50%) aged between 40 and 60 years, and one (16.7%) was aged > 60 years. According to the chi-square test, there was no significant relationship between age and carrier status (P = 0.664). Most of the carriers were female (5 females, 83.3% vs. 1 male, 16.7%; P = 0.199). However, there was no significant difference among carriers in terms of sex distribution. Of the carrier patients, 3 individuals had been on a previous pilgrimage (50%), which did not reveal a statistically significant difference. On the other hand, 4 carriers (66.7%) reported a history of antibiotic use, which did not show a significant relationship with carrier status. Overall, of the 247 who reported previous antibiotic use, 17% were carriers of N. meningitidis, N. sicca, and M. catarrhalis, while of the 175 without previous use of antibiotics, 28 (16%) were carriers of these organisms.
Discussion
Our study showed that, among 422, only 6 individuals (1.4%) were positive for N. meningitidis after the Hajj pilgrimage. Nobody was positive before departure. Meningococcal meningitis is an endemic disease in eastern Mediterranean countries, especially the sub-Saharan meningitis belt. Sudden outbreaks of meningitis have been observed in this region in the past. The annual incidence rate of meningococcal meningitis has been reported between 1 and 5 in every 100,000 people in the eastern Mediterranean region. Nevertheless, the weaknesses of the current health surveillance system of some countries and underreporting to the World Health Organization should be noted (4) . Meningococcal meningitis is considered a huge problem for the domestic health care system of Saudi Arabia too, especially during the Hajj ceremony and afterwards. The Hajj is an annual religious event that (18) . In our study, all 422 subjects who underwent sampling had received the quadrivalent meningococcal vaccine prior to the trip. Of these, 247 reported previous antibiotic usage during pilgrimage (58.5%). The lower carrier status rate of our pilgrims is probably due to previous antibiotic use. However, nobody had received ciprofloxacin prophylaxis before leaving Mecca in our study.
It is necessary that all the pilgrims receive the quadrivalent meningococcal vaccine 10-14 days prior to their trip to prevent infection with N. meningitidis.
